Skip to content

Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility

Tele-Rehabilitation Solutions With Innovative Cores of Extended Reality Based on Metaverse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07456475
Acronym
TERSICORE XRM
Enrollment
25
Registered
2026-03-06
Start date
2025-06-06
Completion date
2027-07-01
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Neurological Disorder, Parkinson Disease, Stroke, Traumatic Brain Injury

Brief summary

The main objective of the TERSICORE project is the development of a new advanced set of exergames in the Metaverse that can be used in all clinical and home rehabilitation devices to improve the cognitive therapy of neurological patients by exploiting the potential of social rehabilitation. Five specific exargames will be developed: a) Cooking therapy (Coordinating in a kitchen to complete a dish through shared activities); b) Escape Room (Exiting a simulated room by solving problems and logic puzzles); c) Nostalgia Bits (Sharing personal reminiscence narratives within simulated spaces); d) NeuroTeam (Mindfulness); and e) Truman Show Exploration of an urban space and role-playing. All exargames will be validated on a small population of neurological patients according to cognitive profile.

Interventions

DEVICECognitive rehabilitation with TERSICORE digital platform

Small groups of end-users will participate in various cognitive tasks carried out in common virtual environments (Metaverse).

Sponsors

Istituto per la Ricerca e l'Innovazione Biomedica
Lead SponsorOTHER
H.S.P.I. s.p.a.
CollaboratorUNKNOWN
Catholic University of the Sacred Heart
CollaboratorOTHER
Fondazione Don Carlo Gnocchi Onlus
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

for patients: * Adult age: 18-85 years * Education: at least 5 years * Cognitive deficits at routine outpatient clinical neuropsychological assessment (at least one test with p.e. 0/1) in subjects with focal neurological insult - (post-Stroke, post-Cranial Trauma) * neurodegenerative disorders - (Multiple Sclerosis, Parkinson's, Mild Cognitive Impairment, AD-like)

Exclusion criteria

for patients: * Severe cognitive impairment MMSE \<22 * Presence of severe deficits in visual acuity, hearing perception, communication and severe dysmetria, such as to interfere with the administration of the activities proposed by TERSICORE * Presence of major psychiatric or neurological pathologies other than the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: Acceptability of Intervention as assessed by TAM3 (Technology Acceptance Model 3) questionnaire.Measured at discharge or 7 days post baselineNumber of participants with high level of behavioral intention (TAM3 score range 1-7), with higher scores indicating greater acceptability of intervention.
Feasibility: Perceived usability of a technological system or application as assessed by SUS (System Usability Scale)Measured at discharge or 7 days post baselineNumber of participants with high level of high level of behavioral intention (SUS score range 1-5), high score indicating greater perceived usability of a technological system or application
Feasibility: User experience of intervention as assessed by UEQ (User Experience Questionnaire)Measured at discharge or 7 days post baselineNumber of participants with high level of comprehensive impression of user experience (UEQ score range 1-7), with higher scores indicating greater impression of user experience.
Feasibility: Intrinsic motivation as assessed by IMI subscale (Intrinsic Motivation Inventory).Measured at discharge or 7 days post baselineNumber of participants with high level of behavioral intention (IMI score range 1-7), with higher scores indicating greater intrinsic motivation.
Feasibility: Sickness elicited by modern virtual reality systems as assessed by SSQ (Simulator Sickness Questionnaire).Measured at discharge or 7 days post baselineNumber of subjects with high level of sickness (SSQ score range 0-3), with higher scores indicating greater simulator sickness.

Secondary

MeasureTime frameDescription
LanguageMeasured at baseline and at the end of the rehabilitation sessions (6 weeks)Changes in phonemic/semantic language ability as assessed by Verbal Fluency
Working memory and attentionMeasured at before and at the end of the rehabilitation sessions (6 weeks)Changes in executive functioning as assessed by Trial Making Test
Visual-spatial abilityMeasured at before and at the end of the rehabilitation sessions (6 weeks)Changes in visual-spatial ability as assessed by Rey Figure
Social metricsMeasure recorded during all rehabilitative sessions (6 weeks)Proximity, frequency of interactions, synchrony and coordination. All these parameters will be measured by sensors
Emotional stateMeasured at baseline and at the end of the rehabilitation sessions (6 weeks)Changes in positive and negative affective states as assessed by Positive and Negative Affect Schedule
Social cognitionMeasured at baseline and at the end the rehabilitation sessions (6 weeks)Changes in theory of mind ability as assessed by Yoni task-48
Gross manual dexterity levelMeasured at baseline and at the end the rehabilitation sessions (6 weeks)Changes in gross manual dexterity level as assessed by Box and Block
Global cognitive functioningMeasured at baseline and at the end the rehabilitation sessions (6 weeks)Changes in general cognitive funtioning as assessed by MoCA
Episodic memoryMeasured at baseline and at the end the rehabilitation sessions (6 weeks)Changes in episodic memory as assessed by FCRST

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026